ZHOG yields 5.23% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ZHOG + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZHOG + PFE for your $10,000?
ZHOG aims to maximize total return through a value-based, unconstrained approach to investing in the US fixed-income market. It looks for undervalued government, corporate, and municipal debt securities, convertibles, commercial papers, mortgage- or asset-backed, preferred stocks, and cash equivalents. Positions are opportunistically initiated in response to changing market dynamics, political shifts, economic trends, interest rate changes, and credit risk analysis. However, during challenging markets, it may temporarily adopt a defensive position, resulting in limitless allocations to cash and prime cash equivalents. The fund invests in securities of any maturity and credit quality, with non-investment grades capped at 20%. The fund may enter lending transactions. Derivatives may also be used to enhance returns. Holdings are sold for more attractive securities or when the portfolio requires repositioning. Before January 2, 2026, the fund traded under the ticker XFIX.
Full ZHOG Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.